Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen
- PMID: 19875179
- PMCID: PMC2787998
- DOI: 10.1016/j.jneuroim.2009.09.020
Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen
Abstract
Prolyl endopeptidase (PE), a protease that cleaves after proline residues in oligopeptides, is highly active in brain and degrades neuropeptides in vitro. We have recently demonstrated that PE, in concert with MMP's, can generate PGP (proline-glycine-proline), a novel, neutrophil chemoattractant, from collagen. In this study, we demonstrate that human peripheral blood neutrophils contain PE, which is constitutively active, and can generate PGP de novo from collagen after activation with LPS. This novel, pro-inflammatory role for PE raises the possibility of a self-sustaining pathway of neutrophilic inflammation and may provide biomarkers and therapeutic targets for diseases caused by chronic, neutrophilic inflammation.
Figures



References
-
- Cunningham DF, O'Connor B. Proline specific peptidases. Biochim Biophys Acta. 1997;1343:160–186. - PubMed
-
- Dresdner K, Barker LA, Orlowski M, Wilk S. Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain. J Neurochem. 1982;38:1151–1154. - PubMed
-
- Fulop V, Bocskei Z, Polgar L. Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis. Cell. 1998;94:161–170. - PubMed
-
- Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P, Blalock JE, Clancy JP. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol. 2007;293:L96–L104. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 082727/Z/07/Z/WT_/Wellcome Trust/United Kingdom
- P30DK740380/DK/NIDDK NIH HHS/United States
- S10 RR019231/RR/NCRR NIH HHS/United States
- P30 CA013148/CA/NCI NIH HHS/United States
- R01 HL102371/HL/NHLBI NIH HHS/United States
- R01 HL087824/HL/NHLBI NIH HHS/United States
- K08 HL092296/HL/NHLBI NIH HHS/United States
- P50 AT000477/AT/NCCIH NIH HHS/United States
- R01 HL07783/HL/NHLBI NIH HHS/United States
- U54CA100949/CA/NCI NIH HHS/United States
- P30AR050948/AR/NIAMS NIH HHS/United States
- P30CA13148/CA/NCI NIH HHS/United States
- U54 CA100949/CA/NCI NIH HHS/United States
- P30 AR050948/AR/NIAMS NIH HHS/United States
- R01 HL090999/HL/NHLBI NIH HHS/United States
- RR19231/RR/NCRR NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- P50AT00477/AT/NCCIH NIH HHS/United States
- R01 HL077783/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous